Linda Collins
Portfolio Lead
Recent publications
-
Randomised Phase II Trial of Olaparib, chemotherapy, or Olaparib and Cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol
Journal article
MANSOURI A. et al, (2020), BMJ Open
-
Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma.
Journal article
Gupta A. et al, (2020), Br J Cancer, 122, 506 - 516